MyFinsight
Home
About
Contact
amlx: the income statement
Download
Download image
Net loss
-$34,386K
(52.70%↑ Y/Y)
Interest income
$1,821K
(-41.22%↓ Y/Y)
Loss before income
taxes
-$34,386K
(52.70%↑ Y/Y)
Total other income,
net
$1,641K
(-44.50%↓ Y/Y)
Other expense, net
-$180K
(-27.66%↓ Y/Y)
Loss from operations
-$36,027K
(52.38%↑ Y/Y)
Total operating
expenses
$36,027K
(-52.64%↓ Y/Y)
Selling, general and
administrative
$16,172K
(-9.29%↓ Y/Y)
Research and development
$19,855K
(-6.51%↓ Y/Y)
Back
Back
Income Statement
source: myfinsight.com
Amylyx Pharmaceuticals, Inc. (AMLX)
Amylyx Pharmaceuticals, Inc. (AMLX)